Epizyme Inc (EPZM)
Epizyme Inc (EPZM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EPZM | AMGN | GILD | CELG | VRTX |
| Company | Epizyme Inc | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.4900 | 309.53 | 65.18 | 108.01 | 419.00 |
| High | 1.5000 | 314.60 | 65.22 | 108.59 | 421.18 |
| Low | 1.4700 | 306.32 | 64.52 | 107.27 | 416.03 |
| Last | 1.4700 | 312.86 | 64.58 | 108.24 | 418.99 |
| Change | -0.0200 | +5.55 | -0.34 | +0.11 | +0.17 |
| % Change | -1.34% | +1.81% | -0.52% | +0.10% | +0.04% |
| Volume | 22,276,000 | 2,921,300 | 6,048,500 | 191,230,496 | 676,100 |
| 20-Day Average Volume | 3,364,145 | 2,907,275 | 7,462,300 | 16,188,930 | 1,114,570 |
| Previous Close | 1.4900 | 307.31 | 64.92 | 108.13 | 418.82 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.4840 | 279.47 | 66.10 | 108.17 | 400.63 |
| 20-Day Raw Stochastic | 25.00% | 84.27% | 5.83% | 63.25% | 80.77% |
| 20-Day Relative Strength | 64.92% | 68.03% | 31.74% | 64.69% | 60.08% |
| Weighted Alpha | -67.50 | +35.65 | -21.62 | +46.30 | +21.42 |
| Today's Opinion | 8% Buy | 56% Buy | 100% Sell | 100% Buy | 56% Buy |
| Previous Opinion | 24% Buy | 56% Buy | 100% Sell | 100% Buy | 56% Buy |
| Last Month's Opinion | 8% Buy | 40% Sell | 100% Sell | 100% Buy | 24% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.68% since 08/04/22 | +12.38% since 05/02/24 | -1.15% since 05/02/24 | -1.97% since 11/13/19 | +4.71% since 05/02/24 |
| Low | 1.4700 on 08/11/22 | 297.52 on 05/06/24 | 64.33 on 05/03/24 | 107.27 on 11/20/19 | 394.03 on 05/07/24 |
| High | 1.5300 on 08/08/22 | 322.60 on 05/03/24 | 66.14 on 05/07/24 | 110.53 on 11/14/19 | 425.65 on 05/08/24 |
| 1-Month | |||||
| %Chg | unch since 07/11/22 | +15.72% since 04/09/24 | -7.66% since 04/09/24 | +5.14% since 10/18/19 | +3.59% since 04/09/24 |
| Low | 1.4500 on 08/04/22 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 102.40 on 10/21/19 | 391.01 on 04/18/24 |
| High | 1.5300 on 08/08/22 | 322.60 on 05/03/24 | 69.76 on 04/10/24 | 110.70 on 11/13/19 | 425.65 on 05/08/24 |
| 3-Month | |||||
| %Chg | +214.30% since 05/11/22 | +7.47% since 02/09/24 | -12.34% since 02/09/24 | +13.63% since 08/20/19 | -0.93% since 02/09/24 |
| Low | 0.4110 on 06/01/22 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 93.41 on 08/23/19 | 391.01 on 04/18/24 |
| High | 1.5800 on 06/27/22 | 322.60 on 05/03/24 | 76.21 on 03/11/24 | 110.70 on 11/13/19 | 437.00 on 02/27/24 |
| 6-Month | |||||
| %Chg | -9.82% since 02/11/22 | +18.48% since 11/09/23 | -13.87% since 11/09/23 | +14.14% since 05/20/19 | +13.68% since 11/09/23 |
| Low | 0.4110 on 06/01/22 | 260.52 on 11/21/23 | 64.33 on 05/03/24 | 89.08 on 07/23/19 | 341.90 on 11/16/23 |
| High | 1.7650 on 03/03/22 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 247,444 | 167,829,040 | 80,407,072 | 77,035,920 | 108,121,632 |
| Shares Outstanding, K | 168,329 | 536,435 | 1,245,077 | 711,714 | 258,053 |
| Annual Sales | 37,430,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 9,869,200,000 |
| Annual Net Income | -251,120,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | 3,619,600,000 |
| Last Quarter Sales | 8,700,000 | 7,447,000,000 | 6,686,000,000 | 4,520,000,000 | 2,517,700,000 |
| Last Quarter Net Income | -55,510,000 | -113,000,000 | -4,170,000,000 | 1,691,000,000 | 968,800,000 |
| 60-Month Beta | -0.41 | 0.60 | 0.22 | 1.41 | 0.39 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.21 on 08/09/22 | 3.96 on 05/02/24 | -1.32 on 04/25/24 | 2.99 on 10/31/19 | 4.76 on 05/06/24 |
| Latest Earnings Date | 08/08/22 | 05/02/24 | 04/25/24 | 10/31/19 | 05/06/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 06/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.50 | 16.11 | 10.99 | 27.81 |